Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV

Journal of Lower Genital Tract Disease

Volumn 11, Issue 2, 2007, Pages 90-97

  Massad, L Stewart ^a   Fazzari, Melissa J ^b   Anastos, Kathryn ^c   Klein, Robert S ^b   Minkoff, Howard ^d   Jamieson, Denise J ^e   Duerr, Ann ^e   Celentano, David ^f   Gange, Stephen ^f   Cu Uvin, Susan ^g   Young, Mary ^h   Watts, D Heather ⁱ   Levine, Alexandra M ^j   Schuman, Paula ^k   Harris, Tiffany G ^b   Strickler, Howard D ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d MAIMONIDES MEDICAL CENTER   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g BROWN UNIVERSITY   (United States)

^h GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k WAYNE STATE UNIVERSITY   (United States)

more..

Author keywords

Cancer prevention; Cervical neoplasia; HIV inwomen

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COLPOSCOPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOLOGY; DNA DETERMINATION; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS EPITHELIUM; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; COLPOSCOPY; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRIDAE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; RISK ASSESSMENT; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 34247164625     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.lgt.0000245038.06977.a7     Document Type: Article

References (24)

1. Mitchell MF, Tortolero-Luna G, Cook E, Whittaker L, Rhodes-Morris H, Silva E. A randomized clinical trial of cryotherapy, laser vaporization, and loop electrosurgical excision for treatment of squamous intraepithelial lesions of the cervix. Obstet Gynecol 1998;92:737-44.
2. Alvarez RD, Helm CW, Edwards RP, Naumann RW, Partridge EE, Shingleton HM, et al. Prospective randomized trial of LLETZ versus laser ablation in patients with cervical intraepithelial neoplasia. Gynecol Oncol 1994;52:175-9.
3. Duggan BD, Felix JC, Muderspach LI, Gebhardt JA, Groshen S, Morrow CP, et al. Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized prospective study. Am J Obstet Gynecol 1999;180:276-82.
4. Wright TC, Ellerbrock TV, Chiasson MA, Van Devanter N, Sun XW, and the New York Cervical Disease Study. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
5. Maiman M, Fruchter RG, Sedlis A, Feldman J, Chen P, Burk RD, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynecol Oncol 1998;68:233-9.
6. Boardman LA, Peipert JF, Hogan JW, Cooper AS. Positive cone biopsy specimen margins in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1999;181:1395-9.
7. Wright TC, Koulos J, Schnoll F, Swanbeck J, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994;55:253-8.
8. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44.
9. Holcomb K, Matthews RP, Chapman JE, Abulafia O, Lee YC, Borges A, et al. The efficacy of cervical conization in the treatment of cervical intraepithelial neoplasia in HIV-positive women. Gynecol Oncol 1999;74:428-31.
10. Robinson WR, Hamilton CA, Michaels SH, Kissinger P. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 2001;184:538-43.
11. Tate DR, Angerson RJ. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol 2002;186:880-2.
12. Chirenje ZM, Susakaniko S, Akino V, Munjoma M, Mlingo M. Effect of HIV disease in treatment outcome of cervical squamous intraepithelial lesions among Zimbabwean women. J Lower Genital Tract Dis 2003;7:16-21.
13. Barkan SE, Melnick SL, Martin-Preston S, Weber K, Kalish LA, Miotti P, et al. The Women's Interagency HIV Study. Epidemiology 1998;9:117-25.
14. Smith DK, Warren DL, Vlahov D, Schuman P, Stein MD, Greenberg BL, et al. Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997;146:459-69.
15. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York: Springer-Verlag, 1994.
16. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91:226-36.
17. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997;16:965-80.
18. Massad LS, Seaberg EC, Watts DH, Hessol NA, Melnick S, Bitterman P, et al. Low incidence of invasive cervical cancer among HIV-infected US women in a prevention program. AIDS 2004;18:109-13.
19. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, et al. HPV type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003;95:1062-71.
20. Schuman P, Ohmit SE, Klein RS, Duerr A, Cu-Uvin S, Jamieson DJ, et al, for the HIV Epidemiology Research Study (HERS) Group. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)- seropositive and at-risk HIV-seronegative women. J Infect Dis 2003;188:128-36.
21. Ahdieh-Grant L, Li R, Levine AM, Massad LS, Strickler HD, Minkoff H, et al. Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Natl Cancer Inst 2004;96:1070-6.
22. Cejtin H, Komanoff E, Massad LS, Korn A, Schmidt JB, Eisenberger- Matityahu D, et al. Adherence to colposcopy among women with HIV infection. J Acquir Immune Defic Syndr 1999;22:247-52.
23. Massad LS, Ahdieh L, Benning L, Minkoff H, Greeblatt RM, Watts H, et al. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2001;27:432-42.
24. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.